Hull, ClaireDekeryte, RutaBuchanan, HeatherKamli-Salino, SarahRobertson, AvrilDelibegovic, MirelaPlatt, Bettina2021-09-112021-09-112020-12-01Hull, C, Dekeryte, R, Buchanan, H, Kamli-Salino, S, Robertson, A, Delibegovic, M & Platt, B 2020, 'NLRP3 inflammasome inhibition with MCC950 improves insulin sensitivity and inflammation in a mouse model of frontotemporal dementia', Neuropharmacology, vol. 180, 108305. https://doi.org/10.1016/j.neuropharm.2020.108305, https://doi.org/10.1016/j.neuropharm.2020.1083050028-3908ORCID: /0000-0002-7852-0749/work/80463636ORCID: /0000-0002-5107-5366/work/160390077ORCID: /0000-0001-6193-3152/work/160847614https://hdl.handle.net/2164/17054Acknowledgments: This study was supported by ARUK project grant PG2017B-11 and ARUK summer scholarship funding from the Scottish ARUK network. The authors would like to thank Prof. Gernot Riedel for his support of the in vivo experimentation.113831324engSDG 3 - Good Health and Well-beingTransgenicKnock-inDiabetesInsulinDementiaNLRP3InflammasomeER stressUPRInflammationR MedicineCellular and Molecular NeurosciencePharmacologyArthritis Research UK (ARUK)PG2017B-11Supplementary DataRJournal article10.1016/j.neuropharm.2020.108305http://www.scopus.com/inward/record.url?scp=85091208330&partnerID=8YFLogxK180